Malik, H., Hudaib, M., & Rehman, A. Vorasidenib- A Paradigm Shift in IDH1- or IDH2-Mutant Low-Grade Glioma Treatment. Pakistan Medical Association.
Chicago Style (17th ed.) CitationMalik, Hurais, Muhammad Hudaib, and Abdul Rehman. Vorasidenib- A Paradigm Shift in IDH1- or IDH2-Mutant Low-Grade Glioma Treatment. Pakistan Medical Association.
MLA (9th ed.) CitationMalik, Hurais, et al. Vorasidenib- A Paradigm Shift in IDH1- or IDH2-Mutant Low-Grade Glioma Treatment. Pakistan Medical Association.
Warning: These citations may not always be 100% accurate.